A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Verastem, Inc.
Verastem, Inc.
Varian, a Siemens Healthineers Company
National Institutes of Health Clinical Center (CC)
Boehringer Ingelheim
Montefiore Medical Center
Nammi Therapeutics Inc
University Health Network, Toronto
Revolution Medicines, Inc.
National Institutes of Health Clinical Center (CC)
Turning Point Therapeutics, Inc.
Abramson Cancer Center at Penn Medicine
AstraZeneca
Memorial Sloan Kettering Cancer Center
Avera McKennan Hospital & University Health Center